Skip to main content

Table 1 Primer sequences and length of PCR/RFLP products

From: Investigation of prognostic value of polymorphisms within estrogen metabolizing genes in Lithuanian breast cancer patients

Polymorphism

Primer sequence*

Length of PCR or RFLP product, bp

Wild type allele

Polymorphic allele

GSTM1 null polymorphism

F: 5′-GAACTCCCTGAAAAGCTAAAGC-3′

215

No product

R: 5′-GTTGGGCTCAAATATACGGTGG-3′

GSTT1 null polymorphism

F: 5′-TTCCTTACTGGTCCTCACATCTC-3′

480

No product

R: 5′-TCACCGGATCATGGCCAGCA-3′

ALB (positive control)

F: 5′-GCCCTCTGCTAACAAGTCCTA′-3

350

-

R: 5′-GCCCTAAAAAGAAAATCGCCAATC′-3

GSTP1 A313G

F: 5′-CCAGTGACTGTGTGTTGATC-3′

189

148; 41

R: 5′-CAACCCTGGTGCAGATGCTC-3′

UGT1A1 A(TA)nTAA

F: 5′-GTCACGTGACACAGTCAAAC-3′

98

100

R: 5′-TTTGCTCCTGCCAGAGGTT-3′

SULT1A1 G638A

F: 5′-GTTGGCTCTGCAGGGTTTCTAGGA-3′

166; 167

333

R: 5′-CCCAAACCCCCTGCTGGCCAGCACCC-3′

  1. *F – forward primer, R – reverse primer.